simvastatin: Simvastatin and Colesevelam Treatment in Patients with Primary Hypercholesterolemia
Description
This data set gives the results from a study investigating the
efficacy and safety of simvastatin and colesevelam treatment in patients with primary hypercholesterolemia.
It shows the sample sizes, the mean LDL cholesterol levels and the number of patients with adverse events after 6 weeks.
The treatment groups are: The Placebo control,
two doses 10 mg and 20 mg of simvastatin and an combined treatment 20 mg + 2.3 g colesevelam.
Usage
data(simvastatin)
Arguments
Format
A data frame with a summary table for ...:
group
A factor with levels "Placebo", "10 mg", "20 mg", "20 mg + 2.3 g Colesevelam" specifying the groups.
sampleSize
A numeric vector, giving the number of patients in the groups.
means
A numeric vector, giving the mean LDL cholesterol levels.
sd
A numeric vector, giving the standard deviation of the LDL cholesterol levels.
adverseEvents
An integer vector, giving the number of patients with adverse events after 6 weeks.
References
Bretz, F., Hothorn, L. A. and Hsu, J. C. (2003):
Identifying effective and/or safe doses by stepwise confidence intervals for ratios
Statistics in Medicine 22, 847-858.